Corporate Member Update: Pfizer- new FDA-approved indication for XALKORI® (crizotinib) capsules
Corporate Member Update: Pfizer- new FDA-approved indication for XALKORI® (crizotinib) capsules
XALKORI® (crizotinib)
January, 2021
Pfizer Oncology is proud to announce a new FDA-approved indication for XALKORI® (crizotinib) capsules. The following information is available for State Society review: